leucine has been researched along with Bile Duct Cancer in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Fu, X; Gu, S; Han, X; He, J; He, W; Qiu, Y; Yan, M; Yan, X; Zhou, Q | 1 |
| Borwornpinyo, S; Chairoungdua, A; Hongeng, S; Janpipatkul, K; Jearawiriyapaisarn, N; Piyachaturawat, P; Suksen, K | 1 |
| TAKAMORI, M | 1 |
3 other study(ies) available for leucine and Bile Duct Cancer
| Article | Year |
|---|---|
Higher content of microcystin-leucine-arginine promotes the survival of intrahepatic cholangiocarcinoma cells via regulating SET resulting in the poorer prognosis of patients.
Topics: Arginine; Bile Duct Neoplasms; Cell Proliferation; Cholangiocarcinoma; Disease-Free Survival; DNA-Binding Proteins; Female; Histone Chaperones; Humans; Leucine; Male; Microcystins; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Proportional Hazards Models; Retrospective Studies; Risk Factors; RNA Interference; RNA, Messenger; RNA, Small Interfering | 2021 |
Downregulation of LAT1 expression suppresses cholangiocarcinoma cell invasion and migration.
Topics: Amino Acids, Cyclic; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Movement; Cell Proliferation; Cholangiocarcinoma; Down-Regulation; Fusion Regulatory Protein 1, Heavy Chain; Gene Expression Regulation, Neoplastic; Humans; Large Neutral Amino Acid-Transporter 1; Leucine; MicroRNAs; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Protein Isoforms; RNA, Messenger; Tumor Cells, Cultured | 2014 |
[Clinical significance of serum leucine aminopeptidase activity in liver, bile duct, and pancreatic diseases].
Topics: Aminopeptidases; Bile Duct Neoplasms; Bile Ducts; Humans; Leucine; Leucyl Aminopeptidase; Liver Diseases; Pancreas; Pancreatic Diseases; Pancreatic Neoplasms | 1963 |